CIRRX | SAREX | CIRRX / SAREX | |
Total Expense Ratio | 1.25 | 0.76 | 164% |
Annual Report Gross Expense Ratio | 1.25 | 0.86 | 145% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 5.256 | 3.384 | 155% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 119M | 7,019% |
Annual Yield % from dividends | 2.37 | 2.78 | 85% |
Returns for 1 year | -3.77 | -4.85 | 78% |
Returns for 3 years | 29.23 | 17.50 | 167% |
Returns for 5 years | 31.47 | 14.60 | 216% |
Returns for 10 years | 52.39 | 30.05 | 174% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VZGRX | 66.47 | 0.33 | +0.50% |
Virtus Zevenbergen Innovative Gr Stk R6 | |||
GSCGX | 36.66 | 0.16 | +0.44% |
Goldman Sachs Large Cap Equity A | |||
CMNWX | 88.16 | 0.35 | +0.40% |
Principal Capital Appreciation A | |||
AFCSX | 19.13 | 0.02 | +0.10% |
American Century Focused Intl Gr I | |||
RYSVX | 215.47 | -0.70 | -0.32% |
Rydex S&P SmallCap 600 Pure Value A |